Qianjiang Yongan Pharmaceutical Co., Ltd.
永安药业
002365
Shenzhen Stock Exchange
Company Profile
(1) Scale Advantage The company has been deeply engaged in the taurine industry for many years and has become the world's largest taurine production base, with a market share of about 50%. The current taurine production capacity has reached 78,000 tons per year. (2) Technological R&D Advantage The company and its subsidiaries have always adhered to technological innovation and product innovation, continuously investing in R&D resources, focusing on breakthroughs and process optimization in the production technology of main products, constantly cultivating and refining core products, and enhancing market competitiveness. The company attaches great importance to the protection of R&D achievements and intellectual property rights, and has obtained multiple patents at home and abroad, and has been rated as a "High-tech Enterprise" for many consecutive years. (3) Brand Advantage Since its establishment, the company has always focused on the cultivation and promotion of the taurine brand, setting the goal of making the "ChuNiu" trademark a strong national brand and fully promoting it to the international market. After years of efforts, the company's "Chuniu" trademark has gained high recognition and reputation both at home and abroad. Under the competitive landscape of the industry, the brand advantage has endowed the company with strong market competitiveness. In addition, the company's core competitiveness has not undergone significant changes.
Full description
The company and its subsidiaries mainly engage in three types of business: First, the research and development, production and sales of taurine products; Second, the research and development, production and sales of health food; Third, the research and development, production and sales of special dietary food (creatine monohydrate). The company is the world's largest taurine production base, accounting for about 50% of the market share. In the first half of 2025, with the completion and commissioning of the first phase of the company's 40,000-ton taurine food additive project (a 20,000-ton taurine food additive project), the company's taurine production capacity will reach 78,000 tons per year. Most of the company's taurine products are exported to all over the world, and it is an important supplier for world-class companies such as Red Bull, Nestle and Coca-Cola. The subsidiary Yong'an Health has always been deeply engaged in the health industry with a global perspective, strategically laying out the fields of health food, medical nutrition, special dietary food and import and export business. It has now built a modern production system covering tablet, powder/particle, liquid, hard capsule and other dosage forms, and has the ability to provide customers with a full-chain comprehensive solution from product research and development, large-scale production to market services. After successfully developing creatine monohydrate products, the subsidiary Ling'an Technology officially transformed into the creatine monohydrate field and is currently focused on the production, research and development and sales of creatine monohydrate.